Addus HomeCare Co. (NASDAQ:ADUS - Get Free Report) CEO R Dirk Allison sold 25,000 shares of the company's stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $124.76, for a total value of $3,119,000.00. Following the sale, the chief executive officer now owns 79,397 shares of the company's stock, valued at $9,905,569.72. This represents a 23.95 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.
R Dirk Allison also recently made the following trade(s):
- On Monday, November 25th, R Dirk Allison sold 12,500 shares of Addus HomeCare stock. The shares were sold at an average price of $123.16, for a total transaction of $1,539,500.00.
Addus HomeCare Price Performance
ADUS traded up $0.33 during trading on Friday, hitting $124.59. The company had a trading volume of 63,465 shares, compared to its average volume of 137,533. Addus HomeCare Co. has a 1-year low of $85.94 and a 1-year high of $136.12. The company has a market cap of $2.26 billion, a PE ratio of 28.51, a P/E/G ratio of 2.11 and a beta of 1.02. The business has a 50-day moving average of $125.12 and a 200-day moving average of $125.74.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last issued its quarterly earnings results on Monday, November 4th. The company reported $1.30 EPS for the quarter, topping the consensus estimate of $1.28 by $0.02. The business had revenue of $289.80 million for the quarter, compared to analysts' expectations of $289.42 million. Addus HomeCare had a net margin of 6.50% and a return on equity of 9.62%. The company's quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter last year, the company posted $1.03 earnings per share. Research analysts forecast that Addus HomeCare Co. will post 4.59 earnings per share for the current year.
Wall Street Analysts Forecast Growth
ADUS has been the topic of several recent research reports. StockNews.com upgraded shares of Addus HomeCare from a "hold" rating to a "buy" rating in a report on Wednesday, December 11th. Oppenheimer upped their target price on Addus HomeCare from $140.00 to $145.00 and gave the stock an "outperform" rating in a research report on Monday, September 23rd. Macquarie reiterated an "outperform" rating and set a $139.00 target price on shares of Addus HomeCare in a report on Monday, November 4th. Stephens upped their price target on Addus HomeCare from $143.00 to $145.00 and gave the stock an "overweight" rating in a report on Wednesday, November 6th. Finally, KeyCorp initiated coverage on shares of Addus HomeCare in a research report on Friday, October 11th. They issued an "overweight" rating and a $150.00 price objective for the company. One analyst has rated the stock with a sell rating, nine have assigned a buy rating and two have assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Buy" and an average target price of $133.67.
Read Our Latest Stock Report on Addus HomeCare
Institutional Investors Weigh In On Addus HomeCare
A number of institutional investors have recently made changes to their positions in the company. Bank of New York Mellon Corp increased its stake in Addus HomeCare by 4.8% during the second quarter. Bank of New York Mellon Corp now owns 129,449 shares of the company's stock valued at $15,030,000 after purchasing an additional 5,952 shares during the last quarter. Natixis Advisors LLC bought a new position in Addus HomeCare in the second quarter worth about $4,271,000. Rhumbline Advisers boosted its stake in Addus HomeCare by 0.6% in the second quarter. Rhumbline Advisers now owns 49,300 shares of the company's stock valued at $5,724,000 after acquiring an additional 293 shares during the period. TD Asset Management Inc boosted its stake in Addus HomeCare by 45.2% in the second quarter. TD Asset Management Inc now owns 4,500 shares of the company's stock valued at $522,000 after acquiring an additional 1,400 shares during the period. Finally, Victory Capital Management Inc. grew its holdings in shares of Addus HomeCare by 136.5% during the second quarter. Victory Capital Management Inc. now owns 80,047 shares of the company's stock valued at $9,294,000 after purchasing an additional 46,199 shares during the last quarter. 95.35% of the stock is currently owned by institutional investors.
About Addus HomeCare
(
Get Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Read More
Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.